glimepiride
Showing 1 - 25 of 128
Ejection Fraction Trial in Seongnam (Gemigliptin, Glimepiride)
Recruiting
- Ejection Fraction
- Gemigliptin
- Glimepiride
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Dec 22, 2022
Drug Use Trial in Jakarta (Glimepiride, Amaryl®)
Completed
- Drug Use
- Glimepiride
- Amaryl®
-
Jakarta, DKI Jakarta, IndonesiaPT Pharma Metric Labs
Jul 20, 2022
Chronic Heart Failure, Type 2 Diabetes, Cardiovascular Mortality Trial in Wuhan (Glimepiride)
Completed
- Chronic Heart Failure
- +3 more
- Glimepiride
-
Wuhan, Hubei, ChinaTongji Hospital
Sep 11, 2022
Diabetes, Type 2, Severe Insulin Deficient Diabetes Trial in Beijing (Glimepiride, Sitagliptin)
Recruiting
- Diabetes Mellitus, Type 2
- Severe Insulin Deficient Diabetes
- Glimepiride
- Sitagliptin
-
Beijing, Please Select, ChinaPeking University People's Hospital
May 18, 2022
Pre-diabetes, Type 2 Diabetes Trial in Philadelphia (Exenatide, Sitagliptin, Glimepiride)
Completed
- Pre-diabetes
- Type 2 Diabetes
- Exenatide
- +2 more
-
Philadelphia, Pennsylvania
- +2 more
May 16, 2022
Type2 Diabetes Trial in Evansville (Bexagliflozin, Metformin, Glimepiride)
Completed
- Type2 Diabetes Mellitus
- Bexagliflozin
- +3 more
-
Evansville, IndianaClinical Research Site
Jul 1, 2021
Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)
Not yet recruiting
- Diabetes Mellitus
- +2 more
- SGLT2 inhibitor
- Glimepiride
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Aug 1, 2023
Diabetic Patients Trial in Damanhur (Omega 3 fatty acids 1000 mg per day + glimepiride 2 mg or 3 mg oral, Glimepiride)
Completed
- Diabetic Patients
- Omega 3 fatty acids 1000 mg per day + glimepiride 2 mg or 3 mg oral
- Glimepiride
-
Damanhūr, El-Bahairah, EgyptDamanhour Medical National Institute
Feb 5, 2021
Replication of LEAD-2 Diabetes Trial in Healthcare Claims Data
Completed
- Diabetes
- Glimepiride
- Liraglutide
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 16, 2021
Replication of GRADE Diabetes Trial in Healthcare Claims Data
Completed
- Diabetes
- Sitagliptin
- Glimepiride
-
Boston, MassachusettsBrigham and Women's Hospital
Oct 18, 2021
Diabetes, Type 2 Trial in East Hanover, Nurnberg (vildagliptin, glimepiride, Metformin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
- +4 more
-
East Hanover, New Jersey
- +1 more
Dec 11, 2020
Type 2 Diabetes Trial (Glimepiride, Alogliptin 25Mg Tab, Alogliptin-Pioglitazone 25 Mg-15 Mg Oral Tablet)
Active, not recruiting
- Type 2 Diabetes Mellitus
- Glimepiride
- +2 more
- (no location specified)
Oct 19, 2020
Type 2 Diabetes Trial in Worldwide (Bexagliflozin, Placebo for Bexagliflozin, Glimepiride)
Non-alcoholic Fatty Liver Disease Trial in Kanazawa (Tofogliflozin, Glimepiride)
Completed
- Non-alcoholic Fatty Liver Disease
- Tofogliflozin
- Glimepiride
-
Kanazawa, Ishikawa, JapanKanazawa University Graduate School of Medical Sciences
Jun 30, 2021
Type2 Diabetes, Cardiovascular Diseases Trial in Ann Arbor (Dapagliflozin, Glimepiride)
Completed
- Type2 Diabetes
- Cardiovascular Diseases
- Dapagliflozin
- Glimepiride
-
Ann Arbor, MichiganUniversity of Michigan
Oct 21, 2020
Type2 Diabetes Trial in Seoul (Glimepiride, Empagliflozin)
Completed
- Type2 Diabetes Mellitus
- Glimepiride
- Empagliflozin
-
Seoul, Korea, Republic ofYonsei University College of Medicine, Department of Internal Me
Aug 24, 2020
Type 2 Diabetes Trial in Worldwide (Sotagliflozin (SAR439954), Glimepiride, Metformin)
Completed
- Type 2 Diabetes Mellitus
- Sotagliflozin (SAR439954)
- +3 more
-
Birmingham, Alabama
- +141 more
Apr 16, 2021
Type 2 Diabetes Trial in Korea, Republic of (metformin, ipragliflozin, glimepiride)
Terminated
- Type 2 Diabetes Mellitus
- metformin
- +2 more
-
Busan, Korea, Republic of
- +7 more
Apr 12, 2020
Type 2 Diabetes, Cardiovascular Disease Trial in Aurora (Sitagliptin, Glimepiride, Placebo)
Completed
- Type 2 Diabetes
- Cardiovascular Disease
- Sitagliptin
- +2 more
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Apr 29, 2019
Diabetes Type 2 Trial in Dresden (Sitagliptin, Glimepiride, Sitagliptin-Placebo)
Terminated
- Diabetes Mellitus Type 2
- Sitagliptin
- +3 more
-
Dresden, GermanyGWT-TUD GmbH / Studienzentrum Hanefeld
Oct 19, 2018
Diabetes, Type 2 Trial in Leicester, Birmingham (Canagliflozin, Repaglinide, Pioglitazone)
Completed
- Diabetes Mellitus, Type 2
- Canagliflozin
- +4 more
-
Leicester, Leicestershire, United Kingdom
- +1 more
Jan 29, 2020
Diabetes, Type 2 Trial in Korea, Republic of (Dapagliflozin, Glimepiride)
Completed
- Diabetes Mellitus, Type 2
- Dapagliflozin
- Glimepiride
-
Ansan-si, Korea, Republic of
- +13 more
Aug 19, 2019
Diabetes, Type 2 Trial in Osaka (Sitagliptin, Glimepiride)
Diabetes Type 2 Trial in Hannover (Empagliflozin, Glimepiride)
Terminated
- Diabetes Mellitus Type 2
- Empagliflozin
- Glimepiride
-
Hannover, GermanyHannover Medical School
Mar 20, 2019